A., G., I., B., I., G., P., J., J.J., R., L., F., . . . B., I. (2022). ß3 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE-HF): A double blind, placebo-controlled, randomized clinical trial.
Citação norma ChicagoA., García-Álvarez, et al. ß3 Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Associated With Heart Failure (SPHERE-HF): A Double Blind, Placebo-controlled, Randomized Clinical Trial. 2022.
Citação norma MLAA., García-Álvarez, et al. ß3 Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Associated With Heart Failure (SPHERE-HF): A Double Blind, Placebo-controlled, Randomized Clinical Trial. 2022.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.